This is the second installment in the series on changes coming to the Clinical Research enterprise that John Neal began in the first article of this series, with the prediction that “major changes are coming that will be disruptive, displacing many people currently working in the industry.”
This prediction, and the others that will follow, were first presented by John Neal, CEO of PCRS Network, at the ACRP 2016 Meeting & Expo in Atlanta in April 2016 in a presentation on the “Future of Clinical Research” during the ACRP Executive Summit on Site Strategies.
For background information as to what is driving the changes John predicts, please see the first article in this series titled “Change is in the air.”
Based on his research, John made eighteen primary predictions. Because he based each prediction on numerous interviews, significant background data, and other relevant information, we are presenting them in a series, with one or more predictions, and the relevant support, presented each week in the ACRP Community Online Forum. Each week John will make another post here, with the details posted in the ACRP Online Forum at http://community.acrpnet.org/home. The ACRP Online Forum is available to all ACRP Members in good standing.
John’s second prediction is . . .
Because sponsors are increasingly seeking efficiencies, and all stakeholders have an interest in minimizing the time required of, and the potential risk to, volunteers who participate in studies, there will be a decrease in the number of single drug studies in the future.
Visit the ACRP Online Community Open Forum at http://community.acrpnet.org/home to read the details behind John’s predictions.
Copyright © 2016, PCRS Network, LLC. ALL RIGHTS RESERVED.